Tymlos 80 MCG dose pen injectr 1.56ML
Ended Awarded Last action
- Contract number
- SPE2DR26FGBR6
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,708
Award facts
- Contract value 100% obligated
- $1,707.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $1,707.57 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for TYMLOS 80 micrograms dose pen injectors (1.56 milliliters). This delivery order, issued on January 21, 2026, with an ultimate completion date of January 22, 2026, represents a single-line purchase under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency. The contract contains no set-aside designation, demonstrating the vendor's competitive capability in unrestricted federal procurement. The product will be performed in Park Ridge, Illinois.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract designated SPE2DR within the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was awarded on November 13, 2025, with a $499.999 billion ceiling value and completion date of December 31, 2036. The PPV-G GEN V represents part of the broader $30.3 billion acquisition strategy to support recurring pharmaceutical and medical supply needs of Department of Defense healthcare facilities worldwide. As a regional prime vendor contractor under this program, DMS Pharmaceutical Group supplies a comprehensive range of branded and generic pharmaceuticals, biologics, specialty medications, and medical consumables to military medical facilities globally, with this particular delivery order fulfilling a specific pharmaceutical requirement for the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FGBR6?
SPE2DR26FGBR6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26FGBR6 worth?
The government has obligated $1,708 on SPE2DR26FGBR6.
Is contract SPE2DR26FGBR6 an order under another contract?
Yes. SPE2DR26FGBR6 is a delivery order under SPE2DR25D9315, an indefinite delivery contract.
Was contract SPE2DR26FGBR6 competed?
The extent of competition for SPE2DR26FGBR6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award